A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo
Public ClinicalTrials.gov record NCT00350636. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multi-Center, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Daily Dosing With Oxybutynin Topical Gel to Treat the Symptoms of Overactive Bladder With a 14-Week Open-Label Safety Extension
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A new drug for overactive bladder is compared to placebo to determine if it is safe and effective. The study lasts approximately 12 weeks.
Study identification
- NCT ID
- NCT00350636
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 789 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2006 (Type not available)
- Primary completion
- May 2007 (Actual)
- Completion
- May 2007 (Actual)
- Last update posted
- May 10, 2010
2006 – 2007
United States locations
- U.S. sites
- 63
- U.S. states
- 29
- U.S. cities
- 63
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Homewood | Alabama | — | — |
| Not listed | Mobile | Alabama | — | — |
| Not listed | Montgomery | Alabama | — | — |
| Not listed | Phoenix | Arizona | — | — |
| Not listed | Tucson | Arizona | — | — |
| Not listed | Little Rock | Arkansas | — | — |
| Not listed | Anaheim | California | — | — |
| Not listed | Buena Park | California | — | — |
| Not listed | Laguna Woods | California | — | — |
| Not listed | Sacramento | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Torrance | California | — | — |
| Not listed | Denver | Colorado | — | — |
| Not listed | Waterbury | Connecticut | — | — |
| Not listed | Aventura | Florida | — | — |
| Not listed | Clearwater | Florida | — | — |
| Not listed | DeLand | Florida | — | — |
| Not listed | Leesburg | Florida | — | — |
| Not listed | Ocala | Florida | — | — |
| Not listed | Plantation | Florida | — | — |
| Not listed | Tallahassee | Florida | — | — |
| Not listed | West Palm Beach | Florida | — | — |
| Not listed | Alpharetta | Georgia | — | — |
| Not listed | Atlanta | Georgia | — | — |
| Not listed | Belville | Illinois | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Melrose Park | Illinois | — | — |
| Not listed | Evansville | Indiana | — | — |
| Not listed | South Bend | Indiana | — | — |
| Not listed | Shreveport | Louisiana | — | — |
| Not listed | Watertown | Massachusetts | — | — |
| Not listed | Saginaw | Michigan | — | — |
| Not listed | Saint Joseph | Michigan | — | — |
| Not listed | Omaha | Nebraska | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | Albany | New York | — | — |
| Not listed | Garden City | New York | — | — |
| Not listed | New York | New York | — | — |
| Not listed | Williamsville | New York | — | — |
| Not listed | Winston-Salem | North Carolina | — | — |
| Not listed | Cleveland | Ohio | — | — |
| Not listed | Columbus | Ohio | — | — |
| Not listed | Lyndhurst | Ohio | — | — |
| Not listed | Bethany | Oklahoma | — | — |
| Not listed | Edmond | Oklahoma | — | — |
| Not listed | Portland | Oregon | — | — |
| Not listed | Allentown | Pennsylvania | — | — |
| Not listed | Newton | Pennsylvania | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | West Reading | Pennsylvania | — | — |
| Not listed | Warwick | Rhode Island | — | — |
| Not listed | Greer | South Carolina | — | — |
| Not listed | Nashville | Tennessee | — | — |
| Not listed | Austin | Texas | — | — |
| Not listed | Corpus Christi | Texas | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Salt Lake City | Utah | — | — |
| Not listed | Richmond | Virginia | — | — |
| Not listed | Spokane | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00350636, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 10, 2010 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00350636 live on ClinicalTrials.gov.